cyc 202 has been researched along with Lung Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Asai, T; Ikari, A; Manabe, A; Matsunaga, T; Onuma, S; Yoshino, Y | 1 |
1 other study(ies) available for cyc 202 and Lung Adenocarcinoma
Article | Year |
---|---|
Upregulation of Chemoresistance by Mg
Topics: A549 Cells; Adenocarcinoma of Lung; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Proliferation; Cisplatin; Cyclosporins; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lung Neoplasms; Lymph Nodes; Magnesium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Reactive Oxygen Species; Roscovitine | 2021 |